Pharmanutra S.p.A. (PHN.MI)

EUR 54.8

(1.86%)

Total Liabilities Summary of Pharmanutra S.p.A.

Pharmanutra S.p.A.'s latest annual total liabilities in 2023 was 58.03 Million EUR , up 17.94% from previous year.
Pharmanutra S.p.A.'s latest quarterly total liabilities in 2024 Q1 was 58.36 Million EUR , up 0.56% from previous quarter.
Pharmanutra S.p.A. reported annual total liabilities of 49.2 Million EUR in 2022, up 87.28% from previous year.
Pharmanutra S.p.A. reported annual total liabilities of 26.27 Million EUR in 2021, up 87.95% from previous year.
Pharmanutra S.p.A. reported quarterly total liabilities of 58.36 Million EUR for 2024 Q1, up 0.56% from previous quarter.
Pharmanutra S.p.A. reported quarterly total liabilities of 56.48 Million EUR for 2023 Q2, up 13.54% from previous quarter.

Annual Total Liabilities Chart of Pharmanutra S.p.A. (2023 - 2015)

Historical Annual Total Liabilities of Pharmanutra S.p.A. (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	58.03 Million EUR	17.94%
2022	49.2 Million EUR	87.28%
2021	26.27 Million EUR	87.95%
2020	13.97 Million EUR	-32.57%
2019	20.73 Million EUR	21.72%
2018	17.03 Million EUR	19.03%
2017	14.3 Million EUR	16.12%
2016	12.32 Million EUR	9.94%
2015	11.2 Million EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	57.03 Million EUR	-2.27%
2024 Q1	58.36 Million EUR	0.56%
2023 Q2	56.48 Million EUR	13.54%
2023 FY	58.03 Million EUR	17.94%
2023 Q3	55.98 Million EUR	-0.88%
2023 Q4	58.03 Million EUR	3.66%
2023 Q1	49.75 Million EUR	1.1%
2022 Q2	35.5 Million EUR	27.41%
2022 Q4	49.2 Million EUR	12.77%
2022 FY	49.2 Million EUR	87.28%
2022 Q1	27.86 Million EUR	6.07%
2022 Q3	43.63 Million EUR	22.9%
2021 Q2	17.54 Million EUR	12.19%
2021 Q1	15.64 Million EUR	11.9%
2021 FY	26.27 Million EUR	87.95%
2021 Q4	26.27 Million EUR	19.4%
2021 Q3	22 Million EUR	25.4%
2020 Q1	- EUR	-100.0%
2020 FY	13.97 Million EUR	-32.57%
2020 Q2	16.95 Million EUR	0.0%
2020 Q4	13.97 Million EUR	5.89%
2020 Q3	13.2 Million EUR	-22.14%
2019 Q2	18.12 Million EUR	-0.01%
2019 FY	20.73 Million EUR	21.72%
2019 Q4	20.73 Million EUR	0.0%
2019 Q1	18.12 Million EUR	6.4%
2018 Q3	17.02 Million EUR	4.0%
2018 Q4	17.03 Million EUR	0.02%
2018 FY	17.03 Million EUR	19.03%
2018 Q1	16.37 Million EUR	14.43%
2018 Q2	16.37 Million EUR	0.0%
2017 Q2	14.73 Million EUR	0.0%
2017 Q1	14.73 Million EUR	19.59%
2017 Q4	14.3 Million EUR	-0.0%
2017 Q3	14.3 Million EUR	-2.9%
2017 FY	14.3 Million EUR	16.12%
2016 FY	12.32 Million EUR	9.94%
2016 Q3	12.32 Million EUR	0.0%
2016 Q1	- EUR	0.0%
2016 Q4	12.32 Million EUR	-0.0%
2015 FY	11.2 Million EUR	0.0%

Peer Total Liabilities Comparison of Pharmanutra S.p.A.

Name	Total Liabilities	Total Liabilities Difference